Oct. 14 Company Quick Takes: Shionogi, Ultragenyx, BridgeBio-Eidos and MolMed

Imbalance in deaths likely focus of Shionogi advisory panel meeting
Briefing documents for an Oct. 16 meeting of FDA’s Antimicrobial Drugs Advisory Committee to discuss IV cefiderocol from Shionogi & Co. Ltd. (Tokyo:4507) to treat complicated

Read the full 353 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE